Lucence Life Sciences Pte. Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lucence Life Sciences Pte. Ltd - overview
Location
Singapore, -, Singapore
Primary Industry
Healthcare
About
Based in Singapore, Lucence Life Sciences Pte. Ltd is a company that develops technology for early cancer detection. The company uses a deep genome intelligence created by different professionals from fields such as oncology, laboratory medicine, technology development, and data science. In May 2023, Lucence Life Sciences Pte.
Ltd raised USD 46. 19 million in series A funding from new investors Centurion Investment Management and Openspace Ventures along with returning investors Great Noble International, Heliconia Capital Management, Lim Teck Lee (Pte. ) Ltd. , Parkway Holdings and SGInnovate.
Lucence Life Sciences Pte. Ltd is a precision oncology company that develops advanced genomic tests for cancer detection and treatment. The company specializes in liquid biopsies non-invasive tests that analyze blood samples to detect genetic changes linked to cancer. Its flagship product, LiquidHALLMARK, uses proprietary AmpliMark technology to identify cancer biomarkers with high sensitivity, supporting personalized treatment decisions.
Current Investors
IHH Healthcare Berhad, Heliconia Capital Management, SGInnovate
Primary Industry
Healthcare
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Bioinformatics, Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.